ASCO GU 2021 Press Releases

Viewing 1-8 of 8 articles

ANZUP Reports A New Class of Effective Therapy for Men with Metastatic Castration-Resistant Prostate Cancer

Weill Cornell Medicine Experts Presenting at 2021 ASCO GU

Foundation Medicine and Its Collaborators Announce New Study Results Further Demonstrating the Clinical Utility of Blood-Based Comprehensive Genomic Profiling in Patients with Advanced Prostate Cancer

Nivolumab in Combination with Cabozantinib Shows Sustained Survival and Response Rate Benefits as First-Line Treatment for Patients with Advanced Renal Cell Carcinoma in the Phase 3 CheckMate -9ER Trial

Janssen Announces Treatment with Apalutamide Significantly Improved Overall Survival in Patients with Metastatic Castration-Sensitive Prostate Cancer

Increase in Metastatic Prostate Cancer Diagnoses Seen After Reduction in PSA Screening in United States

Immunotherapy Nivolumab Doubles Disease-Free Survival in a Type of High-Risk Urothelial Carcinoma

Blue Earth Diagnostics Highlights Presentations on Fluciclovine F 18 at Upcoming 2021 ASCO Genitourinary Cancers Symposium